期刊
CURRENT DRUG TARGETS
卷 13, 期 14, 页码 1720-1729出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138945012804545443
关键词
Bioactive food compounds; butyrate; butyric acid; cancer; cellular targets; chemoprevention; molecular targets; tributyrin
资金
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP]
- Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [CAPES]
- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq]
- FAPESP
Bioactive food compounds (BFCs) exhibit potential anticarcinogenic effects that deserve to be explored. Butyric acid (BA) is considered a promising BFC and has been used in clinical trials; however, its short half-life considerably restricts its therapeutic application. Tributyrin (TB), a BA prodrug present in milk fat and honey, has more favorable pharmacokinetic properties than BA, and its oral administration is also better tolerated. In vitro and in vivo studies have shown that TB acts on multiple anticancer cellular and molecular targets without affecting non-cancerous cells. Among the TB mechanisms of action, the induction of apoptosis and cell differentiation and the modulation of epigenetic mechanisms are notable. Due to its anticarcinogenic potential, strategies as lipid emulsions, nanoparticles, or structured lipids containing TB are currently being developed to improve its organoleptic characteristics and bioavailability. In addition, TB has minimal toxicity, making it an excellent candidate for combination therapy with other agents for the control of cancer. Despite the lack of data available in the literature, TB is a promising molecule for anticancer strategies. Therefore, additional preclinical and clinical studies should be performed using TB to elucidate its molecular targets and anticarcinogenic potential.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据